---
title: "NMN (Nicotinamide Mononucleotide)"
slug: "nmn"
type: "compound"
category: "Longevity"
url: "https://peptidesciencethailand.com/compounds/nmn"
description: "A direct NAD+ precursor that fuels sirtuin activity and cellular energy pathways linked to aging. Longevity research, bioavailability data, and dosing notes."
---
# NMN (Nicotinamide Mononucleotide)

*NAD+ Precursor Nucleotide, Restoring Cellular Energy Metabolism and Sirtuin Activity*

**Category:** Longevity  
**Format:** Lyophilized Vial  
**Amount:** 500mg  
**Purity:** >99% (HPLC)

## Overview

Nicotinamide Mononucleotide (NMN) is a naturally occurring nucleotide and a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), one of the most critical coenzymes in cellular metabolism. With the molecular formula C11H15N2O8P and a molecular weight of 334.22 g/mol, NMN is not a peptide but rather a nucleotide derivative composed of a nicotinamide group, a ribose sugar, and a phosphate group. It has emerged as one of the most intensively researched compounds in the field of aging biology and longevity science, driven primarily by the discovery that NAD+ levels decline substantially with age and that this decline is mechanistically linked to numerous hallmarks of aging.

NAD+ serves as an essential cofactor for over 500 enzymatic reactions in the human body, functioning as both an electron carrier in mitochondrial energy production and a co-substrate for several families of signaling enzymes. Among these, the sirtuins (SIRT1-7), poly(ADP-ribose) polymerases (PARPs), and CD38/CD157 ectoenzymes are particularly significant for their roles in DNA repair, gene expression regulation, epigenetic maintenance, circadian rhythm control, and inflammatory signaling. The age-related decline in NAD+ levels, documented extensively in both animal models and human tissues, compromises the activity of these enzymes and contributes to the progressive functional decline associated with aging.

NMN restores NAD+ levels through a well-characterized biosynthetic pathway. After cellular uptake, NMN is converted directly to NAD+ by the enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT), which exists in three isoforms localized to different cellular compartments: NMNAT1 in the nucleus, NMNAT2 in the cytoplasm and Golgi, and NMNAT3 in the mitochondria. This direct conversion pathway is metabolically efficient, requiring only a single enzymatic step to generate NAD+. The discovery of the Slc12a8 transporter, a specific cell-surface transporter for NMN identified by researchers at Washington University School of Medicine, demonstrated that intact NMN molecules can enter cells directly without prior conversion to nicotinamide riboside (NR), establishing NMN as a direct and efficient NAD+ precursor.

The sirtuin family of NAD+-dependent deacetylases represents one of the most important downstream effector systems activated by NMN supplementation. SIRT1, the most extensively studied mammalian sirtuin, deacetylates numerous protein targets involved in metabolic regulation, stress resistance, and longevity. Key SIRT1 targets include PGC-1alpha (the master regulator of mitochondrial biogenesis), FOXO transcription factors (which control antioxidant defense, autophagy, and cell survival), and p53 (a tumor suppressor with roles in cellular senescence). By restoring NAD+ levels and thereby SIRT1 activity, NMN supplementation reactivates these protective pathways that become compromised during aging.

Research led by Dr. David Sinclair at Harvard Medical School has been particularly influential in establishing the therapeutic potential of NMN. Landmark studies published in Cell and Science demonstrated that NMN administration in aged mice reversed multiple markers of aging, including improved mitochondrial function, enhanced vascular endothelial function, increased exercise endurance, improved insulin sensitivity, and restored gene expression patterns characteristic of younger tissue. These studies showed that 12-month-old mice treated with NMN exhibited metabolic and physiological parameters resembling those of 6-month-old animals, effectively halving their metabolic age.

Mitochondrial function represents a critical target of NMN-mediated NAD+ restoration. NAD+ is essential for the function of Complex I (NADH dehydrogenase) in the mitochondrial electron transport chain, the primary site of cellular energy (ATP) production. Age-related NAD+ decline impairs Complex I activity, reducing mitochondrial membrane potential and ATP synthesis while increasing reactive oxygen species (ROS) production. NMN supplementation reverses these mitochondrial deficits, restoring oxidative phosphorylation capacity and reducing oxidative stress. Studies in aged mice have demonstrated that NMN treatment increases mitochondrial membrane potential, ATP content, and oxygen consumption rates in skeletal muscle, liver, and brain tissue.

The vascular effects of NMN have attracted considerable research interest. NAD+ decline in endothelial cells impairs SIRT1-mediated regulation of endothelial nitric oxide synthase (eNOS), reducing nitric oxide bioavailability and contributing to endothelial dysfunction, a hallmark of vascular aging. Research published in Cell demonstrated that NMN treatment restored endothelium-dependent vasodilation in aged mice, reversed age-related arterial stiffness, and improved cerebral blood flow. These vascular improvements were directly linked to SIRT1-dependent eNOS activation and were abolished in endothelial-specific SIRT1 knockout mice, confirming the causal role of the NAD+/SIRT1 axis.

Human clinical trials of NMN have begun producing meaningful results. A Phase I safety study conducted in Japan confirmed that single oral doses of up to 500mg of NMN were safe and well-tolerated, with no significant adverse effects on clinical chemistry, hematology, or urinalysis parameters. Subsequent intervention trials have demonstrated that oral NMN supplementation (250mg/day for 12 weeks) increased whole blood NAD+ levels, improved muscle insulin sensitivity, and enhanced aerobic capacity in overweight postmenopausal women. A study published in Science by Washington University researchers showed that NMN supplementation improved skeletal muscle insulin signaling and glucose disposal, effects mediated through NAD+-dependent activation of SIRT1 in muscle tissue.

NMN also influences the epigenetic landscape of aging cells. NAD+-dependent enzymes, particularly SIRT1 and SIRT6, play critical roles in maintaining chromatin structure and epigenetic marks (histone modifications and DNA methylation patterns) that regulate gene expression. Age-related NAD+ decline leads to epigenetic drift, the progressive loss of youthful gene expression patterns that contributes to cellular dysfunction. NMN-mediated NAD+ restoration reactivates sirtuin-dependent epigenetic maintenance, helping to preserve the transcriptional programs associated with healthy cellular function. This epigenetic dimension of NMN's activity has implications for the emerging field of epigenetic age reversal.

## Mechanism of Action

### Step 1: Cellular Uptake via Slc12a8 Transporter

NMN enters cells through the Slc12a8 transporter and passive diffusion. Once intracellular, it is positioned for direct enzymatic conversion to NAD+ without the intermediate steps required by other precursors.

### Step 2: NMNAT-Mediated NAD+ Synthesis

Nicotinamide mononucleotide adenylyltransferase (NMNAT) enzymes catalyze the single-step conversion of NMN to NAD+ in the nucleus (NMNAT1), cytoplasm (NMNAT2), and mitochondria (NMNAT3), replenishing compartment-specific NAD+ pools.

### Step 3: Sirtuin Activation (SIRT1-7)

Restored NAD+ levels reactivate sirtuin deacetylases, particularly SIRT1, which deacetylates key targets including PGC-1alpha (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and eNOS (vascular function).

### Step 4: Mitochondrial Electron Transport Chain Restoration

NAD+ serves as the electron carrier for Complex I of the mitochondrial electron transport chain. Replenished NAD+ restores oxidative phosphorylation efficiency, increases ATP production, and reduces excessive reactive oxygen species generation.

### Step 5: Systemic Metabolic and Epigenetic Rejuvenation

Downstream effects include improved insulin sensitivity, enhanced vascular function, increased exercise capacity, and restoration of youthful epigenetic patterns through sirtuin-mediated chromatin maintenance, producing broad anti-aging metabolic effects.

## Researched Benefits

### NAD+ Level Restoration

Human clinical trials demonstrate that oral NMN supplementation (250-500mg/day) significantly increases whole blood NAD+ concentrations. This replenishment reverses the age-associated decline in NAD+ that compromises over 500 enzymatic reactions critical for cellular metabolism, DNA repair, and gene regulation.

### Mitochondrial Function Enhancement

Preclinical studies show that NMN restores mitochondrial membrane potential, ATP synthesis, and oxidative phosphorylation capacity in aged tissues including muscle, liver, and brain. These improvements in cellular energy production translate to enhanced physical endurance and reduced fatigue in animal models.

### Metabolic and Insulin Sensitivity Support

A clinical trial published in Science demonstrated that NMN supplementation improved skeletal muscle insulin signaling and glucose disposal in overweight postmenopausal women. These metabolic benefits are mediated through SIRT1-dependent enhancement of insulin receptor substrate phosphorylation and GLUT4 translocation.

### Vascular and Cardiovascular Health

Research in aged mice showed that NMN treatment restored endothelium-dependent vasodilation, reversed arterial stiffness, and improved cerebral blood flow through SIRT1-mediated activation of endothelial nitric oxide synthase. These vascular improvements have significant implications for cardiovascular aging research.

## Dosage & Administration

| Parameter | Detail |
| --- | --- |
| Protocol | 250-500mg per day, administered orally, typically in the morning |
| Route | Oral administration; sublingual and injectable formulations also studied |
| Duration | Continuous daily supplementation in most research protocols (12 weeks to 12 months studied) |
| Cycle Notes | Unlike many research compounds, NMN protocols typically involve continuous daily supplementation rather than cycling, as the goal is sustained NAD+ level maintenance. Morning dosing is often preferred to align with circadian NAD+ fluctuations and sirtuin-dependent circadian clock regulation. |
| Reconstitution | For research-grade lyophilized formulations, reconstitute with sterile water per protocol specifications. NMN is commonly administered as oral capsules or sublingual powder in clinical research. |

> **Specialist note:** A your specialist will assess baseline NAD+ metabolite levels, metabolic markers, liver and kidney function, and overall health status before initiating NMN supplementation. Individuals taking medications metabolized by NAD+-dependent enzymes or those with active malignancies require careful evaluation due to the broad metabolic effects of NAD+ repletion.

## Compound Reference Data

| Property | Value |
| --- | --- |
| Format | Lyophilized Powder |
| Amount | 500mg per vial |
| Purity | >99% |
| Purity Method | HPLC (High-Performance Liquid Chromatography) |
| Composition | Beta-Nicotinamide Mononucleotide (beta-NMN), nucleotide |
| Molecular Weight | 334.22 g/mol |
| Storage | Store at -20°C for long-term storage. Protect from light and moisture. Short-term storage at 2-8°C acceptable. |
| Appearance | White to slightly yellow crystalline powder |

## Medical Guidance

NMN broadly influences cellular metabolism through NAD+-dependent enzyme systems including sirtuins, PARPs, and CD38. Because NAD+ is involved in over 500 enzymatic reactions, systemic NAD+ repletion has wide-ranging metabolic effects. Individuals with active malignancies require careful consideration, as cancer cells also utilize NAD+ for growth and survival. Those taking diabetes medications, immunosuppressants, or compounds affecting NAD+ metabolism need specialist assessment to avoid unintended interactions.

## Frequently Asked Questions

### What is NMN and is it a peptide?

NMN (Nicotinamide Mononucleotide) is not a peptide. It is a naturally occurring nucleotide, a molecule composed of nicotinamide, ribose, and a phosphate group. NMN serves as a direct biosynthetic precursor to NAD+ (nicotinamide adenine dinucleotide), one of the most important coenzymes in cellular metabolism. It is included in the research compound library due to its significance in longevity research.

### How does NMN differ from NR (nicotinamide riboside)?

Both NMN and NR are NAD+ precursors, but they enter the NAD+ biosynthetic pathway at different points. NMN requires only one enzymatic step (NMNAT) to become NAD+, while NR must first be phosphorylated by NR kinases to form NMN before the NMNAT conversion. NMN also has a dedicated cellular transporter (Slc12a8), allowing intact molecules to enter cells directly. Some researchers consider NMN a more direct and efficient NAD+ precursor.

### What evidence supports NMN for anti-aging?

Extensive preclinical research in mice has demonstrated that NMN reverses multiple aging markers, including mitochondrial dysfunction, vascular stiffness, insulin resistance, reduced exercise capacity, and epigenetic drift. Human clinical trials have confirmed safety, NAD+ elevation, improved insulin sensitivity, and enhanced aerobic capacity. Key studies have been published in Cell, Science, and the Journal of Clinical Endocrinology and Metabolism.

### Is NMN safe for long-term use?

Phase I safety studies in humans have confirmed that single doses up to 500mg and sustained supplementation at 250mg/day for 12 weeks are well-tolerated with no significant adverse effects on clinical chemistry, hematology, or organ function. Longer-term animal studies (12 months) have similarly shown no toxicity. However, comprehensive long-term human safety data beyond 12 months is still being collected through ongoing clinical trials.

### Why is morning dosing typically recommended for NMN?

NAD+ levels naturally fluctuate with circadian rhythm, peaking during the active period and declining during rest. SIRT1 and other NAD+-dependent enzymes play direct roles in circadian clock regulation. Morning NMN administration aligns with the body's natural metabolic upswing and supports circadian NAD+ dynamics. Some research also suggests that high NAD+ levels in the evening could theoretically interfere with sleep-promoting pathways, although this has not been conclusively demonstrated.

## Related Compounds

- /compounds/epithalon
- /compounds/ghk-cu
- /compounds/mots-c